The last year was a challenging one for pharmacists, who began the year facing cash flow challenges and a DIR hangover and ended it with pharmacy benefit manager (PBM) reform being cut from federal legislation. Between these bookends was the closure of more than 2200 pharmacies, which led to the creation of new health care deserts across the US.1
But the news wasn’t all bad: Across the country, more than 100 state-level bills were introduced, many of which expanded pharmacists’ scope of practice. In multiple states, pharmacists can now administer all FDA-approved vaccines, test and treat patients for minor illnesses, and prescribe and dispense…